Bioventus (NASDAQ:BVS) Shares Gap Up – Time to Buy?

Bioventus Inc. (NASDAQ:BVS) gapped up prior to trading on Tuesday . The stock had previously closed at $6.56, but opened at $7.12. Bioventus shares last traded at $7.88, with a volume of 412,672 shares trading hands.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on BVS shares. Wall Street Zen upgraded shares of Bioventus from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. Weiss Ratings reissued a “sell (d-)” rating on shares of Bioventus in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Bioventus currently has an average rating of “Sell”.

Bioventus Stock Up 16.2%

The stock has a 50-day simple moving average of $6.94. The company has a market capitalization of $630.02 million, a price-to-earnings ratio of 13.10 and a beta of 0.80. The company has a current ratio of 1.48, a quick ratio of 0.96 and a debt-to-equity ratio of 1.48.

Bioventus (NASDAQ:BVS) last announced its earnings results on Tuesday, November 4th. The company reported $0.15 earnings per share (EPS) for the quarter. Bioventus had a negative net margin of 0.03% and a positive return on equity of 23.04%.

About Bioventus

Bioventus Inc a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body’s natural healing process in the United States and internationally. The company’s portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products.